title: [Therapy and prognosis of medium and small vessel vasculitis].
authors.forename: Eri
authors.initials: E
authors.lastname: Muso
mesh_terms: D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000150:complications / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D060828:Induction Chemotherapy; D060046:Maintenance Chemotherapy; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D009181:Mycoses / Q000150:complications / Q000517:prevention & control; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control; D010488:Polyarteritis Nodosa / Q000150:complications / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D020551:Pulse Therapy, Drug
chemical_list: D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D008775:Methylprednisolone